Cite
HARVARD Citation
Vanazzi, A. et al. (n.d.). Efficacy of 90Yttrium‐ibritumomab tiuxetan in relapsed/refractory extranodal marginal‐zone lymphoma. Hematological oncology. 32 (1), pp. 10-15. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vanazzi, A. et al. (n.d.). Efficacy of 90Yttrium‐ibritumomab tiuxetan in relapsed/refractory extranodal marginal‐zone lymphoma. Hematological oncology. 32 (1), pp. 10-15. [Online].